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Abstract: Objectives: This study was designed to evaluate bone mineral density (BMD) in healthy female Brazilian 
adolescents in five groups looking at chronological age, bone age, and pubertal breast stage, and determining BMD 
behavior for each classification. 
Methods: Seventy-two healthy female adolescents aged between 10 to 20 incomplete years were divided into five groups 
and evaluated for calcium intake, weight, height, body mass index (BMI), pubertal breast stage, bone age, and BMD. 
Bone mass was measured by bone densitometry (DXA) in lumbar spine and proximal femur regions, and the total body. 
BMI was estimated by Quetelet index. Breast development was assessed by Tanner’s criteria and skeletal maturity by 
bone age. BMD comparison according to chronologic and bone age, and breast development were analyzed by Anova, 
with Scheffe’s test used to find significant differences between groups at P<0.05. 
Results: BMD (g·cm
-2) increased in all studied regions as age advanced, indicating differences from the ages of 13 to 14 
years. This group differed to the 10 and 11 to 12 years old groups for lumbar spine BMD (0.865±0.127 vs 0.672±0.082 
and 0.689±0.083, respectively) and in girls at pubertal development stage B3, lumbar spine BMD differed from B5 
(0.709±0.073  vs 0.936±0.130) and whole body BMD differed from B4 and B5 (0.867±0.056 vs  0.977±0.086 and 
1.040±0.080, respectively). 
Conclusion: Bone mineralization increased in the B3 breast maturity group, and the critical years for bone mass 
acquisition were between 13 and 14 years of age for all sites evaluated by densitometry. 
Keywords: Adolescents, bone mineral density, breast development, female, pubertal events. 
INTRODUCTION 
  Osteoporosis is considered to be one of the most serious 
public health diseases. Studies have shown it to be a 
pediatric disease that manifests during senility, affecting 
30% of all post-menopausal Caucasian women and 70% of 
those aged 80 years, and can result in some type of fracture 
or disability. In addition, the incidence of osteoporosis in 
Asia and Latin America will tend to increase five-fold in the 
next 40 to 50 years due to improving life expectancy. Other 
aspects that have been considered are the demands resulting 
from osteopenia and osteoporosis such as: pain and 
suffering, long-term hospitalization, temporary and 
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permanent disability, and the allocation of substantial 
resources towards the recuperation of these patients [1-3]. 
  Infancy and adolescence are periods where substantial 
physical growth and major changes in body composition are 
seen accompanied by high bone mineralization rates [4-6], 
25% of bone mass is incorporated in the two years around 
peak height velocity (PHV) [5]. Ninety percent or more of 
adult bone mass is obtained during childhood and puberty. 
The impacts and benefits obtained in bone health which will 
be seen throughout life seem to be strongly related to bone 
mass gain during the first 20 years of life [7, 8]. Some 
studies have stated that low bone mass gain during puberty 
could permanently influence bone mineral density and 
content in adulthood [9, 10]. However other recent studies 
have raised doubts as to whether bone mass acquired in this 
stage of life can serve as a “reserve” for future years [11]. 
Perhaps bone mass increase only has a temporary role, 
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life, demonstrating sensitivity in all phases of life to genetic 
factors and adopted lifestyle. Studies have been performed 
supplementing children and adolescents with calcium, 
demonstrating sequential increase in bone mass, however the 
effect on bone mineralization was lost some years after 
supplement suppression. Responses to these studies are still 
open in literature [11] with longitudinal studies needed to 
provide patient follow-up for decades so that the cause – 
effect relationship can be confirmed or refuted, and so that 
all the interest surrounding accurate dynamic evaluation of 
bone tissue during puberty is not just based on this phase 
being critical for increasing bone reserves and minimizing 
losses in later life [5]. It is important to know bone mass in 
adolescents to determine those who present low bone mass 
in virtue of the consequent disorders and chronic diseases 
which may affect them, those with poor accrual, and to have 
a better understanding of bone metabolism [12]. 
  The World Health Organization and the International 
Society of Clinical Densitometry (ISCD) recommend that in 
children and adolescents, interpretation of BMD is 
performed comparing data to Z-score for age and gender, 
and that without definitive agreement, other variables are 
included in studies, such as skeletal maturity obtained by 
measuring bone age (BA) and evaluating puberty stages and 
body composition, which contribute to the understanding of 
bone mineralization [12]. Through such recommendations, it 
can be suggested that to only evaluate bone mass based on 
gender and age, when interested in adolescents, may be 
insufficient as chronological age includes individuals at 
different development stages of biological maturity. 
  Bone mass decline which begins in a person’s 30’s, 
decreases by 1% to 2% each year in women and by 0.3% to 
1% in men; this demonstrates that osteoporosis has a high 
prevalence in both sexes [13]. In light of these statements, 
participants at the 2001 Consensus on Osteoporosis: 
Prevention, Diagnosis, and Treatment, who had previously 
judged it as a natural event linked to aging in women, agreed 
to no longer consider it gender and age related, but consider 
it as a preventable disease [14].
 
  The best way to diagnose osteoporosis in clinical practice 
is by dual-energy X-ray absorptiometry (DXA). DXA is a 
quantitative method for bone mass proposed by the WHO 
which allows accurate estimation of bone mineral mass 
density and content according to age, gender, and race. This 
can help quantify the rate of bone loss and estimate the risk 
of fractures. These characteristics highlight the important 
role of DXA in bone disease diagnosis [15]. 
  Faced with many factors involved in interpreting results 
from bone metabolism evaluation during puberty and their 
probable implications on adult bone health, there is a need to 
increase knowledge and widen application of DXA in 
clinical practice and observation, using it as a tool to help 
understand bone metabolism during puberty in female 
adolescents. Based on these concepts, the objective of this 
study was to evaluate BMD at different ages in healthy 
female Brazilian adolescents and to determine BMD 
behavior in these adolescents in function of chronological 
age, skeletal maturity, and pubertal breast stage. 
 
 
MATERIALS AND METHODOLOGY 
  Healthy female white adolescent volunteers, aged 
between 10 and 20 incomplete years, were invited to 
participate in this study. The volunteers were students at La 
Salle College, Botucatu, São Paulo State (part of the 
Associação Brasileira de Educadores Lassalistas), and Santa 
Marcelina College, a network of private schools in Brazil. Of 
the 497 students in both schools, 72 adolescents were 
included who met all inclusion criteria and participated in all 
evaluations. As all participants were selected from two high 
fee private schools, they were considered as belonging to top 
socioeconomic level. 
  The study was conducted according to guidelines laid 
down in the declaration of Helsinki and procedures involving 
humans and were approved by Botucatu School of Medicine 
Ethics Committee – UNESP, protocol N
o 07/07731-0 CEP. 
Written informed consent was obtained from both 
adolescents and a parent or guardian. 
  Inclusion criteria required adolescents to have a weight 
between the 10 and 90 percentiles, and height between the 10 
and 97.5 percentiles for each age group [16], with an 
adequate Body Mass Index (BMI) for their age [17], and 
regular consumption of dairy products. 
  Exclusion criteria were: those with a history of 
prematurity or low birth weight; those presenting diabetes 
mellitus, acute or chronic undernutrition, congenital or 
acquired bone diseases, gastrointestinal diseases 
accompanied by malabsorption, history of nephropathy with 
or without chronic renal insufficiency, endocrinopathies, 
early or late puberty, chronic drug consumption, cystic 
fibrosis, celiac disease, drug use which negatively affects 
bone metabolism such as anticonvulsants and antacids with 
aluminum, more than 2h/week physical activity, as excessive 
physical exercise interferes with bone mineralization [18]. 
Dietary exclusion criteria were: an exclusively vegetarian 
diet, high dietary fiber, above recommended values of their 
age plus 5 or 10g/day, or over 30g/day [19], caffeine, >300 
to 450mg/day, approximately two or three cups of brewed 
coffee per day [20], or soft drink consumption above 
500ml/day [21, 22], and those not consuming dairy products. 
These rigorous selection criteria were used to minimize 
interference from factors which can affect normal bone 
metabolism during puberty; also excluded were those who 
may have or had used contraception in the 24 months before 
data collection, or those who had been pregnant at any time. 
Exclusion criteria also included non-attendance at any stage 
of data collection. 
  Data collection began at school, where in the first 
instance, adolescents were randomly selected, and those not 
presenting any of the listed exclusion criteria, were invited to 
have their weight and height measured. Those fitting the 
criteria were then questioned about smoking and alcohol 
consumption. Once these questions were satisfied, they were 
invited to participate in the study as volunteers, parents or 
guardians were met to explain methods used, and consent 
requested. Participants and parents or guardians were 
advised that they could retract their consent at any time 
during the study without prejudice. 
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  Volunteers and their parents or guardians were then 
invited to the Adolescent Medicine Outpatient Clinic at 
Botucatu School of Medicine’s University Hospital -
UNESP, where parents and guardians were interviewed, 
followed by a general and special physical examination so 
that any physical alteration could be detected. Secondary 
sexual characteristics were evaluated, and the results 
compared to the Tanner criteria for breast development (B) 
[23]. Skeletal maturation was evaluated by obtaining bone 
age (BA) using the Greulich and Pyle, GP method [24] 
Chronological age (CA), bone age, and pubertal breast stage 
(B) were divided in five groups. Group CA1: was composed 
of 10 year olds, CA2: 11 12 years, CA3: 13  14 years, 
CA4: 15  16 years and CA5: 17  19 year olds. BA groups 
were divided into BA1: adolescents with bone age (BA) of 
10 to 11 years, BA2: BA of 12 to 13 years, BA3: BA of 14 
to 15 years, BA 4: BA of 16 to 17 years, and BA 5: BA of 18 
to 19 years. In sequence dietary characterization was 
measured using a non-consecutive 3 day dietary record [25]. 
Centesimal quantification of food questionnaires was 
performed using a computer analysis system developed by 
São Paulo University Public Health Faculty’s Department of 
Nutrition [26]. 
  Adolescents who completed all earlier steps were then 
submitted to bone mass evaluation by dual-energy X-ray 
absorptiometry (DXA) using a Hologic QDR 2000-Plus 
apparatus from the Clinical Tomography Center – Botucatu. 
Adequate evaluation of bone mass was achieved using 
pediatric software and BMD results were expressed in g·cm
-
2. Measurements were taken of the L1-L4 lumbar spinal 
region and the total proximal femur, including the femur 
neck, trochanteric and intertrochanteric regions, and the 
Ward area and whole body densitometry. The quantity of 
radiation to which the adolescents were exposed was 
considered safe and not prejudicial to their current and future 
life [27, 28]. 
  Data were analyzed by Anova and the Scheffé test to 
compare the difference between group means, with =5% 
and test power equal to 1, using the Sigma Plot Version 11 
software package. These tests were used to compare 
chronological age (CA), bone age (BA), pubertal stage of 
breast (B) and bone density. Graphs include median DXA 
values in relation to age, bone age, and pubertal breast stage. 
Minimum statistical difference was considered at 5%. 
RESULTS 
Characteristics of Adolescents 
  Baseline characteristics of the 72 adolescents studied, 
grouped  according to chronological age (CA), bone age 
(BA), and pubertal breast stage (B), are presented in Table 1. 
The number of participants making up each of the CA, BA, 
and B subgroups is also shown in the table. 
  Chronological age was grouped in the following way: 
CA1, CA2, CA3, CA4, and CA5. There were significant 
increases in body weight, height, and BMI with advancing 
Table 1.  Descriptive Characteristics of Adolescents According to Chronological Age (CA), Bone Age (BA) and Pubertal Breast 
Stage (B) Groups 
 
Groups (Mean±SD)    
   1   2   3   4   5 
Chronological Age (CA)                           
N   8   19   18   14   13 
Weight (Kg)  40.12  ±  9.62  40.32  ±  6.32  48.91  ±  7.15  51.98  ±  5.91
ab  55.73  ±  5.84
ab 
Height (m)  1.44  ±  0.1  1.49  ±  0.08  1.6  ±  0.05
ab  1.61  ±  0.05
ab  1.61  ±  0.05
ab 
BMI (Kg·m
-2) 18.7  ±  2.56  18.02  ±  2.45  18.78  ±  2.07  20.22  ±  2.01  20.75  ±  1.83 
Calcium (mg/day)  702  ±  166  563  ±  289  532  ±  149  489  ±  153  532  ±  267 
Bone Age (BA)                         
N   12   16   16   18   10 
Weight (Kg)  33.02  ±  4.3  45.2  ±  5.73
a  48.86  ±  7.4
a  54.03  ±  6.34
ab  53.71  ±  4.77
a 
Height (m)  1.38  ±  0.05  1.52  ±  0.06
a  1.61  ±  0.06
ab  1.62  ±  0.06
ab  1.63  ±  0.03
ab 
BMI (Kg·m
-2) 16.99  ±  1.57  19.26  ±  2.58  18.74  ±  2.15  20.65  ±  1.97  20.09  ±  1.45 
Pubertal Breast Stage (B)                         
N   8   8   7   28   21 
Weight (Kg)  31.92  ±  4.73  39.18  ±  5.56  45.75  ±  7.98
a  50.27  ±  7.5
ab  52.57  ±  6.48
ab 
Height (m)  1.38  ±  0.05  1.43  ±  0.08  1.54  ±  0.08
a  1.60  ±  0.06
ab  1.61  ±  0.05
ab 
BMI (Kg·m
-2) 16.24  ±  1.62  19.02  ±  2.83  18.81  ±  2.18  19.41  ±  2.19  20.26  ±  1,93 
BMI= body mass index; N= number of patients studied. 
CA1 (10 years old), CA2 (11 12 years old), CA3 (13  14 years old), CA4 (15 16 years old), and CA5 (17 19 years old).  
BA1 (10 11 years bone age), BA2 (12  13 years BA), BA3 (14 15 years BA), BA 4 (16  17 years BA), and BA5 (18  19 years BA). 
B1 (Marshall & Tanner stage I), B2 (Marshall & Tanner stage II), B3 (Marshall & Tanner stage III), B4 (Marshall & Tanner stage IV), B5 (Marshall & Tanner stage V). 
Difference between group 1 and other study groups are shown with the letter 
a, P<0.05. 
Difference between group 2 and other study groups are shown with the letter 
b, P<0.05.
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age, typical of the intense natural physical growth process 
during puberty similar to data from the Center for Disease 
Control and Prevention. The same occurred with bone age 
when the adolescents were classified as BA1 to BA5. Mean 
weight and height for each pubertal breast stage increased 
through the maturation process. 
  Mean calcium ingestion levels from three days dietary 
records were similar for all age groups. BMI did not 
statistically differ between chronological age, bone age, and 
pubertal breast stage groups (Table 1). 
BMD vs Chronological Age (CA) 
 Fig.  (1A) shows mean bone mineral densities evaluated 
by DXA for the lumbar spinal and proximal femur regions 
and the whole body, respectively according to adolescent 
chronological age, subdivided into five groups. Significant 
differences in BMD were seen for 13 to 14 year olds/CA3 
(0.865±0.127 g·cm
-2), 15 to 16 year olds/CA4 (0.881±0.115 
g·cm
-2), and 17 to 19 year olds/CA5 (0.940±0.132 g·cm
-2) 
from 10 year olds/CA1 (0.672±0.082 g·cm
-2) and 11 to 12 
year olds/CA2 (0.689±0.083 g·cm
-2) with P<0.05. The   
same behavior was seen in the proximal femur region and 
whole body, with respective differences in CA3 
(0.906±0.100 g·cm
-2; 0.980±0.102 g·cm
-2) which differed 
from CA1 (0.738±0.131g·cm
-2; 0.819±0.069 g·cm
-2), and for 
CA4 (0.930±0.105 g·cm
-2; 1.019±0.076 g·cm
-2) and CA5 
(0.932±0.073 g·cm
-2; 1.042±0.069 g·cm
-2) which differed 
from CA1 (0.738±0.131 g·cm
-2; 0.819±0.069 g·cm
-2) and 
CA2 (0.770±0.121 g·cm
-2; 0.844±0.085 g·cm
-2). 
 Fig.  (1B) shows mean bone mineral densities for the 
lumbar spinal and proximal femur regions and the whole 
body, respectively according to adolescent bone age, 
subdivided into five groups. Significant differences were 
seen between BA1 (0.639±0.0082 g·cm
-2; 0.660±0.080056 
g·cm
-2; 0.772±0.056 g·cm
-2) and groups BA3 (0.860±0.117 
g·cm
-2; 0.616±0.101 g·cm
-2; 0.994±0.095 g·cm
-2), BA4 
(0.904±0.109 g·cm
-2; 0.945±0.094 g·cm
-2; 1.021±0.076 g·cm
-
2), and BA5 (0.943±0.161 g·cm
-2; 0.909±0.055 g·cm
-2; 1.041 
±0.073 g·cm
-2); with P<0.05 for all evaluated areas. In the 
proximal femur region there were statistical differences 
between BA2 (0.715±0.084 g·cm
-2; 0.811±0.098 g·cm
-2; 
0.870±0.061 g·cm
-2) and BA1. Also BA3 means differed 
from BA1 but not BA2 for this region. 
BMD vs Pubertal Breast Stage (B) 
 Fig.  (1C) shows bone mineralization parameters 
compared with breast stage classification to verify which 
pubertal stages displayed higher bone mass increase. There 
were significant differences in spinal BMD for stages B4 
(0.841±0.115 g·cm
-2) and B5 (0.936±0.130 g·cm
-2) against 
B1 (0.624±0.053 g·cm
-2), B2 (0.670±0.098 g·cm
-2) and in B5 
(0.936±0.130 g·cm
-2) against B3 (0.709±0.073 g·cm
-2). 
Significant differences were seen in proximal femur BMD 
for B4 (0.907±0.086 g·cm
-2) and B5 (0.930±0.099 g·cm
-2) 
against B1 (0.663±0.079 g·cm
-2) and B2 (0.696±0.097 g·cm
-
2) with P<0.05. B3 mean BMD (0.832±0.125 g·cm
-2) did not 
demonstrate significant difference. In total body evaluation, 
B4 (0.977±0.086 g·cm
-2) and B5 (1.040±0.080 g·cm
-2) 
differed from B1, B2, and B3 (0.763±0.062 g·cm
-2, 
0.810±0.071 g·cm
-2, 0.867±0.056 g·cm
-2, respectively;   
 
P<0.05). B1 and B2 BMD levels between the lumbar region, 
proximal femur region, and whole body were not 
significantly different; notably however, in B3 these 
indicators showed a marked biological increase in the spinal 
lumbar region and whole body. 
 
Fig. (1).  A,  B,  C – Mean and Standard error of Bone Mineral 
Density (BMD) of lumbar spine, proximal femur and whole body 
according to Chronological age (CA), Bone age (BA) and pubertal 
stage of breast (B).  
Difference between Group 1 and other study groups are shown with 
the letter 
a, P<0.05. 
Difference between Group 2 and other study groups are shown with 
the letter 
b, P<0.05. 
Difference between Group 3 and other study groups are shown with 
the letter 
c, P<0.05. 
Anova, Scheffé test. 
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DISCUSSION 
  The importance of this study is reinforced by the rigid 
inclusion and exclusion criteria which differentiate it from 
other studies to date in specialized literature performed on 
populations from other countries. Several authors have 
included or at least not excluded subjects with a previous 
history of premature birth, low weight, ethnic differences, 
changes in nutritional state, those performing intense 
physical exercise and using medications which often 
negatively or positively interfere with bone metabolism, as 
well as many other situations which can change bone mass 
growth in this stage of life. This study mainly focuses on 
understanding bone mass gain in a population of healthy 
white female adolescents from a high socioeconomic level, 
following the most rigid inclusion criteria and its relationship 
with chronological age, bone age, and pubertal development, 
classified by breast evaluation. Adolescents who have 
participated in other regular physical activities, in addition to 
those run at school, and are considered low impact short 
duration <2hrs/week, were also excluded as studies in 
literature confirmed that practicing physical exercise 
encourages bone mass gain, which could introduce other 
ways of interfering with results from this uniformly selected 
sample [18, 29]. 
  During puberty, there are two nearly simultaneous 
biological events; one is the physical growth spurt, 
characterized by peak height velocity (PHV), and the other 
which consists of reaching peak bone mass increase, 
stressing that PHV occurs two years before menarche, 
around 11.3 years old, and bone mass increase close to first 
menarche. Scientific literature has shown that bone mass 
deposition gains momentum a little after PHV in girls, 
generally occurring when they are in stages B3-B4, 
according to Tanner criteria [30]. It is said that 90% of bone 
mass gain occurs in the first 20 years of life with exponential 
growth during adolescence. Baroncelli et al. (2005) [5] 
showed that at least 25% of bone mass is achieved in the two 
years encompassing peak height growth (PHV) and Cassidy 
(1999) [31], the WHO, and ISCD [12, 32] proposed that to 
accept a diagnosis of low bone mass in children and 
adolescents, results should also be compared to bone age and 
sexual maturity levels. This refinement in the interpretation 
of increment or no increment in bone mass for individuals 
exposed to large physical changes, places great emphasis on 
understanding bone mineralization, due to the peculiarities of 
this phase of life, related to growth and biological 
maturation. 
  In relation to bone age, our adolescents showed advances 
in relation to chronological age, but within the normal 
standard deviation considered by literature. According to 
Marshall & Tanner (1986) [33], the possibility of obtaining a 
“uniform” bone age by reaching  puberty in normal 
individuals cannot be defined, as values can normally vary 
by around two standard deviations. However the same 
authors showed that skeletal maturation age has a strong 
correlation with puberty, as sexual steroid hormones released 
into the blood help advance bone age, an event which has a 
strong relationship with events seen in puberty. For our 
group of adolescents, mean BA (14.31 years) was higher 
than mean chronological age (13.70 years). In Table 1 it can 
be shown that adolescents distributed over groups CA and 
BA are of one homogenous form, despite this a large 
percentage presented advanced breast stages B4 and B5 
(68%), suggesting that interpretation of BMD results, taking 
into account only chronological and not maturational criteria, 
could be insufficient in some situations that speed up or slow 
down pubertal development. 
  BMD results indicated increasing values in all studied 
regions; the lowest observed in 10 year-olds and the largest 
in 17 to 20 year-olds. Boot et al. (1997) [34] also evaluated 
peak bone mass in a longitudinal study with both male and 
female adolescents; they found that peak BMD for the 
lumbar spine and whole body occurred between the ages of 
18 and 20 years in females. After more than a decade, these 
same authors presented results from statistical models, using 
data taken from transverse longitudinal studies, to evaluate 
peak bone mass attainment in 501 healthy subjects of both 
sexes, performing whole body, lumbar spine, and femoral 
neck DXA at three different times, the second 4.3 years after 
the first, and the third 6.1 years after the second. They 
concluded that for the 360 female individuals in their 
sample, peak BMD occurred in the lumbar region at 17.8 
years and in the whole body at 19.9 years of age [10]. In our 
study, differences began in the 13 to 14 years age group, and 
when the girls reached pubertal development stage B4, this 
could be seen in all lumbar spine, proximal femur, and total 
body regions [35]. Visually, this gain began to accelerate 
(Fig. 1C) when the girls entered into B3, which did not mean 
that bone mass deposition did not continue at all evaluated 
sites in stages B4 and B5. Other studies have shown that 
BMD values in the lumbar spine (L1 to L4) for girls are 
higher than for boys in the 12 to 15 age band, possibly due to 
the effects of hormonal cascade, which advances their 
pubertal events compared to boys [5]. The higher 
susceptibility of the female to sexual steroid action is in 
trabecular bone which is mainly found in vertebra [5]. 
Trabecular bone is metabolically more active and responsive 
to functional changes in the organism which explains why 
this is where bone loss starts in both sexes in the third decade 
of life and total bone mass declines 6 to 8% every ten years. 
We can also see that the response to a drop in estrogen is 
more intense, with a big acceleration in bone remodeling and 
a loss of 5% to 10% bone mass per year in 40% of women 
suffering post menopause osteoporosis, or that with a drop in 
estrogen bone remodeling accelerates where reabsorption 
activity is higher and at the end of each cycle there is a 
significant decline in bone mass [5]. 
 Kalkwarf  et al. (2007) [36] concerned with determining 
bone mass in children and adolescents between 6 and 16 
years of age, identified that the lack of bone mineral gain in 
this stage of life is linked to microarchitecture disruption 
during senility. They evaluated bone mineral density in 1554 
Americans from different geographical locations, using 
DXA in 761 boys and 793 girls, of which 462 were 
pubescent girls from different ethnic origins. Our results are 
similar to their results when analyzing the 50 percentile for 
non-blacks in the lumbar spine, proximal femur, and whole 
body. 
  However, despite rigid inclusion and exclusion criteria, 
they included children small for their gestational age and 
those whose BMI was up to the 97
th percentile, therefore 
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to what percentage of their individuals were included in 
these conditions, making up the final sample, one could infer 
that their results, relative to the medians, were displaced up 
or down [36]. Our study looked at the association of BMD 
with bone age and secondary sexual signs, also suggested by 
Cassidy (1999) [31], the WHO and ISBD, a situation that 
undoubtedly adds value to our results allowing readers to 
interpret them against a series of biological maturation 
indicators, which helps in the explanation and understanding 
of bone mineralization gain. 
  As to the role of dietary calcium; daily ingestion varied 
from 489±153mg/day to 702±166mg/day, with a mean of 
563±215mg/day. Although these values were less than the 
1300mg/day recommended in Dietary Reference Intakes 
(DRI) for a population of the same age band, we were able to 
detect an increase in BMD. Studies by other authors on 
BMD and calcium intake have shown that in some countries, 
average consumption by female adolescents is lower than 
DRI values, but with evident BMD gain [37, 38]. For 
example, El Hage et al. (2010) [39] showed that daily 
calcium intake in Danish eutrophic adolescents was 
783±285mg/day with BMD values of 0.891±0.108 g·cm
-2for 
the lumbar region and 0.756±0.114 g·cm
-2 for the femoral 
neck, which are similar to our results. This suggests that the 
complex mechanisms surrounding ingested calcium use and 
its bioavailability could both be involved in this question 
[40]. 
 Molgaard  et al. (2009) [40] reported a recent review by 
Cochrane identified that calcium supplement in children and 
adolescents has little effect on BMD in arm bones; stressing 
that spinal BMD was more subject to estrogen exposure than 
to increased calcium intake or supplements. 
  Estrogen (ER) and Vitamin D (VDR) receptors may be 
distributed in a different form on different bone types, as 
well as having individual differences. Genetic studies on the 
variability of Vitamin D and estrogen receptors have 
suggested that individuals who express specific types of 
receptors can have different types of BMD in function of 
VDR and ER receptors. Thus the use of calcium and its 
influence on BMD could be linked to the genetic variability 
of these receptors
 [40]. 
  Our study did not give special attention to understanding 
these mechanisms or the possible relationship between 
ingestion and bone mass uptake, as it was a transverse study; 
however we suggest that future studies look at the 
importance of adequate calcium intake and its repercussions 
in bone mass increase in the Brazilian population. We stress 
that cohort studies on adolescent populations who ingest DRI 
recommended levels of micronutrients, would be extremely 
important in bone mass gain comparisons. 
  Such considerations highlight the need to stress the 
importance of dietary education with the aim of promoting 
an adequate intake of this and other groups of nutrients, and 
to contribute in the specific case of calcium, to the subject of 
youngsters obtaining adequate peak bone mass, thus 
reducing the risks of low bone mass which in future life can 
lead to osteopenia and osteoporosis [41]. 
  This study has some limitations, such as the small 
number of adolescents making up the sample, being a 
transverse study, as well as using only one manufacturer’s 
densitometry apparatus (Hologic), which could make 
comparisons with our results difficult for other services 
when using different DXA equipment. Also hormone level 
measurements could have added to this study, as estrogen 
and insulin-like growth factor-1 (IGF-1) are essential for 
reaching  physical maturity, growth, and adequate bone 
mineralization. Following adolescent distribution by Tanner 
stages, it is possible to show that they present adequate 
endogen and estrogen production rates as 56 (78%) 
presented stages  B3, physical evidence of their hormonal 
changes. Thus, indirectly by observing puberty stages, it is 
possible to infer that increased estrogen production 
modulated the GH-IGF axis, and that hormonal cascade 
acted on linear growth and bone mineralization, as stated in 
literature [42]. 
  Therefore, interpreting bone mass evaluation by DXA 
using standard curves based on the main variables (ethnicity, 
age, gender, anthropometric measurements, and pubertal 
development) should guarantee a better interpretation of 
BMD in clinical practice and guarantee a new understanding 
of bone mass and its variations in adolescence, data which 
will certainly contribute to a better quality of life in 
adulthood, as adult osteoporosis is inversely proportional to 
peak bone mass acquired in infancy and adolescence. 
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